Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted an opinion recommending the approval of ...

France's Sanofi said its Dupixent drug jointly developed with Regeneron advanced toward a new indication for chronic hives in the European Union, while the U.S. Food and Drug Administration extended ...

Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to ...

Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinionRecommendation for adults and ...

The first immune checkpoint inhibitor that can be administered via subcutaneous injection in just 1 to 2 minutes has emerged.

Sanofi ( NASDAQ: SNY) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT ...

Dear Annie: I read the letter from “Sideline Mom With a Heavy Heart” with deep empathy. My husband coached both of our sons, now grown men, in baseball, wrestling and football. While he was not as ...

Dear Eric: We have a condo at the beach that has a pool. There is a couple (whom we are not friendly with) that we know through other people, and they have a condo in a nearby building without a pool.

A woman has shared devastating home camera footage capturing the last time she heard her 15-year-old son Parker's voice. Jess Coats, 47, told Newsweek: "His last moments on camera are hard to watch—my ...

PARIS, Sept 4 (Reuters) - Twenty-six nations have pledged to provide postwar security guarantees to Ukraine, which will include an international force on land, sea and in the air, French President ...

Despite hitting its efficacy targets in the Phase III COAST-1 study, Sanofi’s amlitelimab remains “meaningfully inferior” to Dupixent, according to analysts at Leerink Partners. Sanofi’s ...